The speakers explore the potential of technology in cancer treatment and highlight promising drug candidates in the pipeline, as well as the groundbreaking work of Verve Therapeutics in potentially eradicating heart disease. They discuss the transformative impact of artificial intelligence and biotech on healthcare.
Garvin Jabusch, Co-Founder and CIO of Green Alpha Advisors, discusses ESG investing.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.